Diabetes Clinical Trials in Denver

Showing 401-420 of 560 trials

Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion

NCT02603510

Primary Objective: * Assess the safety of SAR342434 and Humalog when used in external pumps. Secondary Objectives: * Intervals for infusion set changes. * Incidence of insulin pump alarms for infusion set occlusion. * Patient observation of infusion set occlusion. * Adverse events including bruising at the infusion site and injection site reactions.

Type 1 Diabetes Mellitus

Sanofi27 participantsStarted Nov 2015

Little Rock, Arkansas, United States • Denver, Colorado, United States

COMPLETEDPhase 3< 1 mile

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

NCT01131676

The aim of the present study is to investigate the safety of BI 10773 treatment in patients with Type 2 Diabetes Mellitus and high cardiovascular risk.

Diabetes Mellitus, Type 2

Boehringer Ingelheim7,064 participantsStarted Jul 2010

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +612 more locations

Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Diabetes Trials in Other Cities

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Text Messaging for Weight Loss

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Study of an Investigational Glucose Meter System

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

Multiple Ascending Dose Study in Subjects With Type 2 Diabetes

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Glucose Meter Study

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

Evaluation of the A1CNow+ Test Kit

Other Conditions in Denver